Palbociclib 1,2,3,4-Tetra-O-acetyl-β-D-glucuronic Acid Methyl Ester

Ref. TR-P139920

Produktinformation

• Name: Palbociclib 1,2,3,4-Tetra-O-acetyl-β-D-glucuronic Acid Methyl Ester
• Synonyme: (2R,3R,4S,5S,6S)-2-(4-(6-((6-Acetyl-8-cyclopentyl-5-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl)amino)pyridin-3-yl)piperazin-1-yl)-6-(methoxycarbonyl)tetrahydro-2H-pyran-3,4,5-triyl Triacetate
• Marke: TRC
• Beschreibung: Applications Palbociclib 1,2,3,4-Tetra-O-acetyl-β-D-glucuronic Acid Methyl Ester is an intermediate in synthesizing Palbociclib N-β-D-Glucuronide Sodium Salt (P139910), a derivative of Palbociclib (P139900) which is an experimental drug for the treatment of breast cancer being developed by Pfizer. It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6.References Finn, R., et al.: Breast Cancer Res., 11, 5 (2009)

Chemische Eigenschaften

• Molekulargewicht: 763.79
• Formel: C₃₇H₄₅N₇O₁₁
• Farbe/Form: Neat
• InChl: InChI=1S/C31H42N6O3/c1-30(2,32)28(39)34-26(18-23-20-33-25-15-10-9-14-24(23)25)27(38)37-17-11-16-31(21-37,29(40)36(5)35(3)4)19-22-12-7-6-8-13-22/h6-10,12-15,20,26,33H,11,16-19,21,32H2,1-5H3,(H,34,39)/t26-,31-/m1/s1
• InChI Key: InChIKey=VQPFSIRUEPQQPP-MXBOTTGLSA-N
• SMILES: CN(C)N(C)C(=O)[C@@]1(Cc2ccccc2)CCCN(C(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)C(C)(C)N)C1